急诊科急性心力衰竭诊断与管理的常见误区
该综述评估了急诊科急性心衰评估与管理中的多个常见误区。急性心衰是异质性综合征,表现多样。医生常依赖利钠肽,但支持其使用的证据有争议,不应孤立使用;胸片常被视为最可靠的影像检查,但床旁超声对急性心衰的评估更敏感、更特异。利尿剂是急性心衰管理的基础,但在肺水肿中应在给予血管扩张剂(如硝酸甘油)之后才使用;高剂量硝酸甘油治疗肺水肿安全有效,可减少ICU入住需求。低血压性心源性休克经典首选多巴胺,但去甲肾上腺素与更好的结局和更低的死亡率相关。急性心衰患者的分流复杂,风险分层工具结合其他评估可让医生安全地让患者出院并随访。
要点
- 肺水肿患者应先给予血管扩张剂(如硝酸甘油),之后再给利尿剂。
- 高剂量硝酸甘油治疗肺水肿安全有效,可减少ICU入住需求。
- 低血压性心源性休克中,去甲肾上腺素与更好的结局和更低的死亡率相关,而多巴胺是经典首选。
- 床旁超声对急性心衰的评估比胸片更敏感、更特异;利钠肽不应孤立使用。
- 风险分层工具结合其他评估可让急性心衰患者安全出院并随访。
适用人群与场景
- 急诊科就诊的急性心衰患者,包括表现为肺水肿和低血压性心源性休克的患者。
处置流程与药物剂量
- 肺水肿患者应在给予血管扩张剂(如硝酸甘油)之后才使用利尿剂。
- 高剂量硝酸甘油用于肺水肿安全有效,可减少ICU入住需求。
- 低血压性心源性休克患者使用去甲肾上腺素,与更好的结局和更低的死亡率相关。
研究设计与关键结果
- 综述评估了急性心衰评估与管理中的多个误区:临床评估、利钠肽使用、胸片与超声使用、硝酸甘油与利尿剂、血管升压药选择及分流。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 急性心衰评估中不应孤立依赖利钠肽,床旁超声比胸片更敏感、更特异。
- 肺水肿患者给利尿剂前应先给血管扩张剂(如硝酸甘油),高剂量硝酸甘油安全有效并可减少ICU入住需求。
- 低血压性心源性休克中,去甲肾上腺素与更好的结局和更低的死亡率相关,而非经典首选的多巴胺。
- 急性心衰分流复杂,风险分层工具结合其他评估可安全出院并随访。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Acute heart failure (AHF) accounts for a significant number of emergency department (ED) visits, and the disease may present along a spectrum with a variety of syndromes.
OBJECTIVE: This review evaluates several misconceptions concerning heart failure evaluation and management in the ED, followed by several pearls.
DISCUSSION: AHF is a heterogeneous syndrome with a variety of presentations. Physicians often rely on natriuretic peptides, but the evidence behind their use is controversial, and these should not be used in isolation. Chest radiograph is often considered the most reliable imaging test, but bedside ultrasound (US) provides a more sensitive and specific evaluation for AHF. Diuretics are a foundation of AHF management, but in pulmonary edema, these medications should only be provided after vasodilator administration, such as nitroglycerin. Nitroglycerin administered in high doses for pulmonary edema is safe and effective in reducing the need for intensive care unit admission. Though classically dopamine is the first vasopressor utilized in patients with hypotensive cardiogenic shock, norepinephrine is associated with improved outcomes and lower mortality. Disposition is complex in patients with AHF, and risk stratification tools in conjunction with other assessments allow physicians to discharge patients safely with follow up.
CONCLUSION: A variety of misconceptions surround the evaluation and management of heart failure including clinical assessment, natriuretic peptide use, chest radiograph and US use, nitroglycerin and diuretics, vasopressor choice, and disposition. This review evaluates these misconceptions while providing physicians with updates in evaluation and management of AHF.
参考来源
- Long B, Koyfman A, Chin EJ, et al. Misconceptions in acute heart failure diagnosis and Management in the Emergency Department. Am J Emerg Med. 2018. PMID: 29887195. doi:10.1016/j.ajem.2018.05.077
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。